• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804350-15
Medical Device Problem Code Device Damaged by Another Device (2915)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/26/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device was received.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The powerturn guide wire will be filed under a different medwatch report number.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion located in the left anterior descending coronary artery (lad).Two powerturn guide wires were advanced to their intended location, one wire down the diagonal branch.The 3.5x15mm xience skypoint was implanted, without issue, in the lad lesion.During removal of the guidewire from the diagonal branch, resistance was noted, the guidewire became stretched and, the skypoint stent was explanted.A new guide wire was positioned and a 3.5x18mm xience skypoint was advanced and implanted in the lesion without issue.There was no adverse patient sequela and no clinically significant delay in procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Only the stent was returned for analysis.The stent was returned stretched, smashed and caught proximal to the tip of the guidewire likely due to interaction with the guidewire during removal.The reported device damaged by another (damaged-explanted) could not be confirmed as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely the guidewire interacted with the implanted stent during removal causing the reported device damaged by another device (damaged-explanted).There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16423006
Report Number2024168-2023-01797
Device Sequence Number5685660
Product Code NIQ
UDI-Device Identifier08717648233395
UDI-Public08717648233395
Combination Product (Y/N)Y
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number1804350-15
Device Catalogue Number1804350-15
Device Lot Number2090841
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/03/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/30/2023
Supplement Date Received by Manufacturer03/01/2023
Initial Report FDA Received Date02/22/2023
Supplement Report FDA Received Date03/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age65 YR
Patient SexMale
-
-